[go: up one dir, main page]

AU2001256773A1 - Regulation of mt1-mmp activity - Google Patents

Regulation of mt1-mmp activity

Info

Publication number
AU2001256773A1
AU2001256773A1 AU2001256773A AU5677301A AU2001256773A1 AU 2001256773 A1 AU2001256773 A1 AU 2001256773A1 AU 2001256773 A AU2001256773 A AU 2001256773A AU 5677301 A AU5677301 A AU 5677301A AU 2001256773 A1 AU2001256773 A1 AU 2001256773A1
Authority
AU
Australia
Prior art keywords
regulation
mmp activity
mmp
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001256773A
Other languages
English (en)
Inventor
Kenichi Obata
Motoharu Seiki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FUJICHEMICO Ltd
Original Assignee
FUJICHEMICO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FUJICHEMICO Ltd filed Critical FUJICHEMICO Ltd
Publication of AU2001256773A1 publication Critical patent/AU2001256773A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489Metalloendopeptidases (3.4.24)
    • C12N9/6491Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486Metalloendopeptidases (3.4.24)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/02Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001256773A 2000-05-19 2001-05-18 Regulation of mt1-mmp activity Abandoned AU2001256773A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000147739 2000-05-19
JP2000-147739 2000-05-19
PCT/JP2001/004166 WO2001088131A1 (en) 2000-05-19 2001-05-18 Regulation of mt1-mmp activity

Publications (1)

Publication Number Publication Date
AU2001256773A1 true AU2001256773A1 (en) 2001-11-26

Family

ID=18653884

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001256773A Abandoned AU2001256773A1 (en) 2000-05-19 2001-05-18 Regulation of mt1-mmp activity

Country Status (4)

Country Link
US (1) US20040120954A1 (ja)
EP (1) EP1288297A4 (ja)
AU (1) AU2001256773A1 (ja)
WO (1) WO2001088131A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1197456B1 (de) 2000-10-10 2004-07-28 Grapha-Holding AG Verfahren und Anordnung zur Herstellung gefalzter Druckerzeugnisse
WO2004072639A1 (de) * 2002-05-29 2004-08-26 Helmut Ponta Verfahren zur identifizierung von verbindungen zur unterdrückung metastasierender tumorzellen
JP2004175689A (ja) * 2002-11-25 2004-06-24 Kureha Chem Ind Co Ltd 癌転移抑制剤
US8722102B2 (en) * 2010-01-29 2014-05-13 Dechra Veterinary Products Llc Compositions for treatment of skin and ear infections
US9133239B2 (en) 2010-04-20 2015-09-15 The Research Foundation For The State University Of New York Compositions and methods for inhibiting matrix metalloproteinase (MMP)-mediated cell migration
CN102718840B (zh) * 2012-08-06 2014-05-14 中山大学 一种人mmp-14抗原、相应单克隆抗体及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3802560B2 (ja) * 1994-03-17 2006-07-26 マックスデルブリュック−チェントラム フュール モレクラール メディツィン マトリックス金属プロテアーゼのdna配列、その調製および使用
GB9615976D0 (en) * 1996-07-30 1996-09-11 Center For Clinical & Basic Re The use of proteinase inhibitors for the prevention or reduction of bone resorption

Also Published As

Publication number Publication date
WO2001088131A1 (en) 2001-11-22
EP1288297A4 (en) 2004-11-17
EP1288297A1 (en) 2003-03-05
US20040120954A1 (en) 2004-06-24

Similar Documents

Publication Publication Date Title
AU2001229712A1 (en) Reduction of hair growth
AU2002253836A1 (en) Aptamer-mediated regulation of gene expression
AU2002220082A1 (en) Imaging of enzymatic activity
AU2002234010A1 (en) Benzamidine derivatives
AU2001269123A1 (en) Regulation of human dipeptidyl-peptidase iv-like enzyme
AU2001263850A1 (en) Pyrimidine-sulfonamides having endothelin-antagonist activity
AU2001256773A1 (en) Regulation of mt1-mmp activity
AU2001281950A1 (en) Regulation of human thimet oligopeptidase-like enzyme
AU2002219992A1 (en) Targeted regulation of gene expression
AU2001274080A1 (en) Regulation of human transketolase-like enzyme
AU2001281939A1 (en) Regulation of human alpha-hydroxysteroid dehydrogenase-like enzyme
AU2001269095A1 (en) Regulation of human caspase-1-like protease
AU2002215942A1 (en) Regulation of human carboxylesterase-like enzyme
AU2002210525A1 (en) Regulation of human phospholipase-like enzyme
AU2001285782A1 (en) Regulation of human phosphodiesterase-like enzyme
AU2001281969A1 (en) Regulation of human carboxylesterase-like enzyme
AU2002221781A1 (en) Regulation of human inositolpolyphosphate 5-phosphatase
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU2002215923A1 (en) Use of medicaments
AU2002212246A1 (en) Regulation of human serine palmitoyltransferase-like enzyme
AU2002216106A1 (en) Regulation of human ubiquitin-conjugating enzyme e2
AU2001256350A1 (en) Regulation of human lysostaphin-like protease
AU5033101A (en) Regulation of human heparanase-like enzyme
AU3734901A (en) Use of amidines
AU3376501A (en) Improvement of implantation rate